Your browser doesn't support javascript.
loading
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.
Monteiro, Fernando Sabino Marques; Fiala, Ondrej; Massari, Francesco; Myint, Zin W; Kopecky, Jindrich; Kucharz, Jakub; Büttner, Thomas; Grande, Enrique; Bourlon, Maria Teresa; Molina-Cerrillo, Javier; Pichler, Renate; Buchler, Tomas; Seront, Emmanuel; Ansari, Jawaher; Bamias, Aristotelis; Bhuva, Dipen; Vau, Nuno; Porta, Camillo; Fay, Andre Poisl; Santoni, Matteo.
Afiliación
  • Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, RS, Brazil; Hospital Sirio Libanês, Brasilia, DF, Brazil; PUCRS School of Medicine, Porto Alegre, RS, Brazil. Electronic address: fsabinocba@gmail.com.
  • Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital, Charles University, Pilsen, Czech Republic; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia.
  • Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY.
  • Kopecky J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czechia.
  • Kucharz J; Department of Uro-oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland.
  • Büttner T; Department of Urology, University Hospital Bonn (UKB), 53127 Bonn, Germany.
  • Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Bourlon MT; Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Molina-Cerrillo J; Department of Medical Oncology, University Hospital Ramón y Cajal, Madrid, Spain.
  • Pichler R; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
  • Buchler T; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic.
  • Seront E; Department of Medical Oncology, Centre Hospitalier de Jolimont, Haine Saint Paul, Belgium.
  • Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates.
  • Bamias A; 2nd Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Bhuva D; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India.
  • Vau N; Urologic Oncology, Champalimaud Clinical Center, Lisbon, Portugal.
  • Porta C; Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
  • Fay AP; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, RS, Brazil; PUCRS School of Medicine, Porto Alegre, RS, Brazil.
  • Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy.
Clin Genitourin Cancer ; 22(2): 305-314.e3, 2024 04.
Article en En | MEDLINE | ID: mdl-38087702
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2024 Tipo del documento: Article